Summary Bacillus Calmette-Guthin (BCG) has been used for many years to treat cancer of the urinary bladder. It constitutes effective intravesical therapy of carcinoma in situ and recurrent superficial bladder cancer. Although the mechanism of action is unknown, most evidence suggests an immune-mediated mechanism. BCG treatment is known to increase cytokine production in the urinary bladder. As cytokines may induce nitric oxide synthase (NOS) activity and as nitric oxide (NO) The aim of this study w as to in estigate whether NO production max be involved in BCG-mediated anti-tumour activitv in the treatment of human bladder cancer. The study wxas approx ed by the local ethics committee.
Unnarx bladder cancer is the fourth most frequent form of cancer among men and the ninth among Women. and 50 500 new-cases and 10 600 deaths were estimated in the United States in 1995 (Wingo et al. 1995) . In the future many of these patients w-iII be treated xxith bacillus Calmette-Gumrin (BCG) . which proxides effective treatment of recurrent superficial bladder cancer as w ell as carcinoma in situ (Morales et al. 1976 : Lamm. 1992 ). Although the actual mechanism of the BCG-associated anti-tumour activity is unknown. most of the available evidence indicates an immune-mediated mechanism (Ratliff et al. 1986: Jackson and James. 1994) . Several cvtokines.
e.a. interleukins (LL-1. IL-'. IL-6. L-8). tumour necrosis factor alpha (TNF-a). and interferon gamma dIFN-y). hax-e been identified in the patients urine after BCG instillations (Ratliff et al. 1986 : Fleischmann et al. 1989 : Jackson et al. 1995 . Various cvtokines haxe been shown to induce the sxnthesis of nitric oxide svnthase (NOS) (Knowles and Moncada. 1994) . and induction of NOS causes sustained release of nitric oxide (NO). resulting in high local concentrations that mav mediate cytostatic and cxtotoxic effects (Hibbs et al. 1990) . NO has been implicated in the cytotoxic activity of macrophages against tumour cells (Hibbs et al. 1990 ). Indeed. BCG was one of the first compounds shown to induce NOS-mediated cvtotoXic effects (Hibbs et al. 1990 ). Interestinglx. the BCGmediated tumoricidal effect in a murine ovarian teratocarcinoma model has been reported to be dependent on NO (Farias-Eisner et al. 1994 . When BCG wxas administered together w-ith the NOS inhibitor NG-monomethxl-L-arginine (L-NMMA) The aim of this study w as to in estigate whether NO production max be involved in BCG-mediated anti-tumour activitv in the treatment of human bladder cancer. The study wxas approx ed by the local ethics committee.
MATERIALS AND METHODS Patients
In eight patients being treated with BCG (Tice. 5 x RIP CFU.
Organon Teknika. Boxtel. The Netherlands) for recurrent superficial bladder cancer (stage Ta. grade G2. n = 5) or carcinoma in situ CIS. n = 3.) bladder biopsy specimens were taken during routine cystoscopy 4 weeks after the last instillation. All patients had received at least six BCG instillations.
In 12 patients with recurrent papillary bladder cancer (TaG1. n = 2: TaG2. n = 10). biopsy specimens from the tumour were taken during cy stoscopv. Ten patients x ith recurrent papillary bladder cancer (TaG2. n =10) judged to be in remission by cystoscopy and bladder wash-out cvtologx sen-ed as control subjects. Biopsy specimens were taken from the normal mucosa and immediately frozen in liquid nitrogen. Table 1 The calcium-dependent and calcium-independent NOS activity (mean ± s.e.m.) in urinary bladder biopsy specimens from normal bladder (n = 10). bladder tumour (n = 12). and BCG-treated patients (n = 8) measured as picomoles L-[U-'Cjcitrulline formed per minute per gram tissue (wet weight) DL-dithiothreitol. 10 ic ml-' trypsin inhibitor. 10 jg ml-, leupeptin. phenylmethylsulfonyl fluoride 100 jg ml' and 2 jg ml-' aprotinin (adjusted to pH 7.2 at 20'C with 1 as hydrochloric acid). The homogenate was centrifuged at 10 000 g for 30 min at 4'C. and the supernatants collected and stored on ice before use. To measure the NOS activity in the supernatants 20 pA was added to tubes prewarmed to 3TC. containing 100 jil of a buffer consisting of 50 mmr potassium phosphate. pH 7.2. 50 mM Lvaline. 100 gom NADPH. 1 mM L-Citrulline. 20 jiM L-arginine and L-[U-'-C]arginine (Amersham. 150 000 d.p.m.). 1.2 mm calcium chloride. Duplicate incubations for 10 min at 37"C were performed for each sample in the presence or absence of either EGTA (2 n'mI) or EGTA plus Nw-monomethyl-L-arginine (2 mt each). to determine the level of the calcium-independent and calcium-independent activity respectively. The reaction was terminated by removal of the substrate and dilution by addition of 1.5 ml of 1:1 (V/V) water/Dowex AF 50W-X8. pH 7.5. Water (5 ml) was added to the incubation mix. and 2 ml of the supematant was removed and 
NO excretion
The NO excretion in the urinav bladder was measured bv introducing 100 ml of air (NO < five parts per billion: p.p.b.) into the urinary bladder during cystoscopy. The air was aspirated into a syringe after incubation for 5 min and immediately injected into a chemiluminescence NO analx ser (CLD 700. Eco Physics.
Durnten. Smitzerland) and peak levels of NO were recorded. were lNsed bv addition of 0.01%;-Triton X-100. Bisbenzimide H33258 (Sigma) was added to the suspension at a concentration of 2 jg ml and the fluorescence was measured in a fluorometer (Hoefer TKO 100). Calf thy mus DNA extract (Sigma) with known concentrations was used to plot a standard curve for DNA concentrations. The total DNA concentration was directlx correlated with the cell densitv. as assessed bv counting cells in a haemocvtometer.
PH]Thymidine uptake
Cells Were pulsed with ['H]thy-midine ( 1 Ci per well) 2 h before harvest. At harvest. the medium was discarded. cells were washed with PBS and the supernatant w as discarded. Ice-cold 10%T trichloroacetic acid (1 ml) >-as added to each well and incubated for 15 mmn. Following repeated washings with saline phosphate buffer. the cell pellet >-as extracted with 0.5 ml of 0.1 '1 sodium hvdroxide. The suspension was dissolved in 5 ml of scintillation liquid and counted in a beta-counter.
Cell viability
At har est. the medium was removed and saved in centrifuge vials. The wells were then washed with calcium-free PBS and the supernatant >-as added to the centrifuge vials. Cells wvere then detached from the culture >-ells by adding 0.057 trypsin in 0.02%7 EDTA for 5 min at room temperature. The cells were resuspended in the centrifuge xials and spun at 1200 r.p.m. for 5 mMin. The supernatant was discarded and the cells were resuspended in 0.2'7% trxpan blue (Gibco). Viability was assessed by counting the proportion of viable cells in a haemocvtometer.
Statistics
The statistical significance of differences between control and treatment groups was determined using the tw-o-tailed unpaired ttest. Significance Awas defined as P < 0.05.
RESULTS

NOS activity
Calcium-dependent NOS activity A-as found in the mucosa of normal urinary bladder biopsy specimens. but no calcium-independent activitv was detected (Table 1) . Tumour tissues showxed sianificant calcium-independent NOS activity-and the calcium-dependent NOS activit-w as similar to the activity in normal mucosa (Table 1 ). In the mucosa of BCG-treated patients. there >-as a fourfold increase in calcium-dependent NOS actix it!. as compared with normal control subjects (Table 1) . Patients treated with BCG also showxed a high calcium-independent NOS activity ( Table 1) .
Immunohistochemistry of tissue sections
In both normal urothelium ( Figure 1A ) and tumour tissue (Figure  1 B) . a marked eNOS-like immunoreactixitv >-as seen in the urothelial cells. eNOS-like immunoreactivitv-was also found in BCG-treated bladder mucosa (not shown>. Furthermore. eNOSlike immunoreactivitxwas evident in the endothelium of blood vessels (Ficure IC). nNOS-like immunoreactivit) could not be detected in normal mucosa. tumour tissue or BCG-treated mucosa.
although subepithelial nNOS-like immunoreactivit) >-as detected in some nerves in the normal bladder ( Figure ID) . iNOS-like immunoreactivitx could not be adequately demonstrated as both the monoclonal and polyclonal iNOS antibodies used show ed staining of the urothelial cells. blood Xessels. neurons and macrophages. suggesting that the iNOS antibodies w ere nonspecific and stained all NOS isoenzx mes (not shoxxn).
Direct measurements of gaseous NO in the urinary bladder in vivo
In BCG-treated patients. the mean NO concentration in the air aspirated from the bladder was 30 times (450 ± 240 p.p.b. ) higher than in control subjects ( 15 ± 4 p.p.b.) (Figure 2 ). releasing compound S-nitroso-N-acetylpenicillarnine (SNAP 10-1000 gm) (Figure 3 ). There was no significant difference in the sensitivity of the different cell lines. The same pattern was seen using sodium nitroprusside (SNP, 0.3-1.5 mM), although a higher concentration was needed (not shown). The inhibition of cell growth was found to be partly due to decreased cell viability as assessed by the trypan blue exclusion method After 24 h of incubation with 100 PM SNAP, the viable cell count amounted to 70% of that of control subjects (not shown). No reduction in the DNA concentration was seen when normal urothelial cells were incubated with SNAP (10-1000 pM) under the same conditions ( Figure 3A) . However, inhibition of [3H]thymidine incorporation was seen when normal urothelial cells were incubated with SNAP at the highest concentration used (1000 i.m) ( Figure 3B ).
DISCUSSION
Since the first report of the use of intravesical BCG for the treatment of superficial bladder cancer (Morales et al, 1976) , clinical trials have confirmed that BCG is an effective immunomodulator that yields superior results to those of chemotherapy (Lamm, 1992) . It is now apparent that BCG exerts its effect both directly on the tumour cells and via the immune system (Jackson and James, 1994). As an increase in cytokine production has been demonstrated after BCG instillations (Ratliff et al, 1986; Fleischmann et al, 1989; Jackson et al, 1995) and cytokines may cause a sustained release of high concentrations of NO, resulting in cytostatic and cytotoxic effects on tumour cells (Hibbs et al, 1990) , it seemed logical to investigate the possible involvement of NO in BCG-mediated anti-tumour effects. Interestingly, BCG was one of the first compounds used to induce NOS activity in murine macrophages when the activated macrophage cytotoxic effect was studied (Hibbs et al, 1990 ).
We found a higher degree of both calcium-dependent and calcium-independent NOS activity in the urinary bladder following BCG treatment for superficial bladder cancer. The increased calcium-dependent activity was probably due to an increased activity of eNOS, localized to the urothelial cells. Thus, the luminal There are. however. reports on cytokine induced calcium-dependent NOS activity in endothelial cells (Rosenkrantz-Weiss. 1994 ). It has also been shown that oestrogen increases the calcium-dependent NOS activity in various tissues. including the urinary bladder (Weiner et al. 1994 : Ehren et al. 1995 . The mechanism underlving the increase in calcium-dependent and calcium-independent NOS activity after BCG treatment is not clear at the present time. Both an increase in the amount of NOS present and changes in co-factor concentrations could be possible explanations. as indicated by previous studies (Rosenkrantz-Weiss. 1994 : Weiner et al. 1994 ).
Although it is clear that NOS activity in the bladders of BCGtreated patients results in a hiah local concentration of NO. it is still not clear whether it is calcium-dependent or calcium-independent NOS activity that is responsible for the increased production of NO in vivo. Thus. in vitro. the calcium-dependent NOS activity dominated over the calcium-independent activity. but this does not necessarily reflect the actual in -i-o situation. Significant calcium-independent activity in bladder tumours was seen. whereas no calcium-independent activitv was detected in the normal bladder mucosa. Thus. in bladder tumours. both calciumdependent and calcium-independent activity was found. This is not surprising as it has been shown that several tumour cell lines express NOS (Radomski et al. 1991 : Jenkins et al. 1995 . and NOS is also present in human ovarian. uterine and breast cancer (Thomsen et al. 1994 (Thomsen et al. . 1995 . However. the role of NO production in tumour growth is unclear. It has been shown that the NOS activity in the tumour is correlated with the tumour growth rate (Jenkins et al. 1995) . Furthermore. NO may also be important for maintaining the blood supply to the turnour by dilatinc the malignant vessels (Andrade et al. 1992) . In low concentrations. NO can stimulate cell growth. whereas high concentrations inhibit cell growth (Thomae et al. 1995 
